← All news
Markets

Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania Transcript

1 source ·2 articles ·Sep 23, 21:32 UTC Rapport Therapeutics

Covered by 1 outlet

All coverage · 2 articles